These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6603694)

  • 1. On the role of the thymus during the generation of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors.
    Wagner H
    Transplant Proc; 1983 Jun; 15(2):1693-7. PubMed ID: 6603694
    [No Abstract]   [Full Text] [Related]  

  • 2. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of thymic T cells by MHC alloantigen requires syngeneic, activated CD4+ T cells and B cells as APC.
    Strutt TM; Uzonna J; McKinstry KK; Bretscher PA
    Int Immunol; 2006 May; 18(5):719-28. PubMed ID: 16569677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes in class I MHC molecules influencing recognition by allo- or self + TNP-reactive cytotoxic T-cell clones and by monoclonal antibodies.
    Davignon JL; Albert F; Boyer C; Hua C; Buferne M; Guimezanes A; Schmitt-Verhulst AM
    Transplant Proc; 1983 Dec; 15(4):2080-5. PubMed ID: 6608811
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one and a half receptor model for MHC-restricted antigen recognition by T lymphocytes.
    Pernis B; Axel R
    Cell; 1985 May; 41(1):13-6. PubMed ID: 2581695
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thymic epithelium induces tolerance to allogeneic major histocompatibility complex class I antigens.
    Hoffmann MW; Heath WR; Allison J; Miller JF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):289-90. PubMed ID: 8438303
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
    Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
    Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T; Staege MS; Reichmann G; Reske-Kunz AB
    J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells, the MHC, and function.
    Forman J
    Immunol Rev; 1984 Oct; 81():203-19. PubMed ID: 6439622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice.
    Kruisbeek AM; Sharrow SO; Mathieson BJ; Singer A
    J Immunol; 1981 Nov; 127(5):2168-76. PubMed ID: 6975310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.
    Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K
    Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. 1975.
    Bevan MJ
    J Immunol; 2005 Dec; 175(11):7069-84. PubMed ID: 16301608
    [No Abstract]   [Full Text] [Related]  

  • 18. MHC bias of Mls-1 recognition is not influenced by thymic positive selection.
    Nguyen P; Woodland DL; Blackman MA
    Cell Immunol; 1996 Feb; 167(2):224-9. PubMed ID: 8603431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell reactivity to polymorphic MHC determinants. III. Alloreactive and allorestricted T cells.
    Kabelitz D; Heeg K; Wagner H; Reimann J
    Curr Top Microbiol Immunol; 1986; 126():275-89. PubMed ID: 3487427
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of lymphopoiesis as a function of the thymic microenvironment. Use of CD8+ cytotoxic T lymphocytes for cellular immunotherapy of human cancer.
    Bodey B
    In Vivo; 1994; 8(5):915-43. PubMed ID: 7727741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.